Potential role of skin in SARS-CoV-2 infection
Potential role of skin in SARS-CoV-2 infection
批准号:
10593622
负责人:
Irina Budunova
金额:
$24.74万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-21 至 2025-06-30
关键词:
2019-nCoV3-DimensionalACE2AcuteAddressAfrican AmericanAfrican American populationAtopic DermatitisBindingBiological FactorsBiologyBiopsyCOVID-19COVID-19 cytokine stormCOVID-19 impactCOVID-19 pathogenesisCOVID-19 patientCOVID-19 riskCOVID-19 vaccineCapsid ProteinsCellsChickenpoxChronicCommunitiesCoronavirusDataDeath RateDermatologicDevelopmentDisparityEpidermisEpithelial CellsEthnic OriginEthnic PopulationEyeFutureGene ExpressionGenesGlycoproteinsHeartHerpes Simplex InfectionsHerpes zoster diseaseHispanicHumanIL17 geneIL4 geneImmune EvasionIn VitroIndividualInfectionInfectious Skin DiseasesInflammationInflammatoryInflammatory ResponseInterferon Type IIInterleukin-1 betaInterleukin-13Interleukin-6KidneyKnowledgeLatinoLentivirusMessenger RNAModelingMolecularMolluscum contagiosum virusMorphologyMultiple Organ FailureMutateMutationNoseNot Hispanic or LatinoOrganPancreasPathogenesisPatientsPeptide HydrolasesPopulationPreventionPropertyProteinsPsoriasisRNARaceReceptor CellRecoveryReporterReportingRoleRouteSARS-CoV-2 infectionSARS-CoV-2 variantSamplingSignal TransductionSkinSkin ManifestationsSocioeconomic FactorsSurfaceSymptomsTMPRSS2 geneTNF geneTestingTissuesTomatoesVariantViralViremiaVirusWorkairway epitheliumcytokinecytokine release syndromeexperimental studyhospitalization ratesin vitro Modelinfection rateinnovationinterleukin-22keratinocytemutantnovelprogramsracial populationreceptor bindingresponseskin disorderskin woundthree dimensional cell culturetranscriptome sequencingtransmission processvaccine accessvaccine hesitancyviral RNAwoundwound healing
中文摘要
尽管研发出了抗SARS-CoV-2疫苗,新冠肺炎仍是一场全球灾难。这是到期的
由于全球疫苗供应有限,疫苗接种犹豫不决,以及SARS新变种的出现--
CoV-2。此外,还缺乏关于SARS-CoV-2生物学的完整知识,包括潜在的
传播途径和不同的发病机制,特别是在种族群体,如非裔美国人(AA)和
与非西班牙裔白人(WNH)相比,受新冠肺炎影响的西班牙裔/拉美裔不成比例
人口。导致这些地区高感染率、住院率和死亡率的生物因素所起的作用
团体仍有待调查。SARS-CoV-2进入细胞依赖于病毒尖峰蛋白(S)的结合
对宿主细胞受体ACE2及其被宿主蛋白酶TMPRSS2的引发/切割。人们普遍认为,
SARS CoV-2进入人体的主要途径是呼吸道上皮细胞。但是,其他区域中的单元格
包括心脏、肾脏、胰腺、眼睛和皮肤(主要是表皮)在内的组织/器官也表达ACE2和
TMPRSS2.最近的一些研究表明,皮肤可能直接成为SARS-CoV-2的靶标。事实上,病毒RNA
在皮肤活检中也能检测到衣壳蛋白。重要的是,一些炎症性皮肤病,如
牛皮癣和特应性皮炎,显著增加了患新冠肺炎的风险。这与研究结果相关联。
ACE2和TMPRSS2在银屑病患者皮损和创面皮肤中的表达增加
皮肤。此外,新冠肺炎与皮肤病的直接或有时持续表现有关
这可能是由于SARS-CoV-2直接(局部)或全身(通过循环病毒)感染而发生的。
然而,人类健康或发炎的皮肤在SARS-CoV-2进入和新冠肺炎中的潜在作用
发病机制尚未解决。已知肿瘤坏死因子-α、白介素6、白介素1β和干扰素-γ等细胞因子参与了
在细胞因子风暴期间,不同炎症性皮肤病的发生和水平增加
经常与病毒血症、多器官衰竭和严重致命新冠肺炎的发展相关
。
在我们的试点中
实验表明,肿瘤坏死因子-α+白介素6+白介素1β+干扰素-γ联合应用可显著诱导血管紧张素转换酶2的表达
和TMPRSS2在由原代人表皮角质形成细胞制成的3D人类皮肤等效物(3D-HSE)中
(Nhek)。根据这些新发现,我们推测发炎的皮肤可能会被野生型SARS感染。
CoV-2病毒及其新出现的突变变种,据报告特定种族的感染率较高
人群可能依赖于SARS-CoV-2进入细胞所涉及的蛋白质的较高表达水平。为了测试这些
假设,我们将使用伪型Spike(S)蛋白含慢病毒报告病毒,2D-和3D-HSE
由AA、西班牙裔和WNH角质形成细胞制成的培养物经与COVID相关的细胞因子鸡尾酒处理后-
19种细胞因子风暴(肿瘤坏死因子-α+白介素6+白介素1b+干扰素-γ)或细胞因子(白介素17+白介素22+肿瘤坏死因子α)或
特应性皮炎(IL4+IL13)在体外皮肤模型中的分子和形态变化。
英文摘要
COVID-19 continues to be a global catastrophe despite development of anti-SARS-CoV-2 vaccines. This is due
to the worldwide limited vaccine availability, vaccination hesitancy, and the emergence of new variants of SARS-
CoV-2. Moreover, there is a lack of complete knowledge about SARS-CoV-2 biology, including potential
transmission routes and variable pathogenesis, especially in ethnic groups, such as African American (AA) and
Hispanic/Latino that were disproportionally affected by COVID-19 compared to White Non-Hispanic (WNH)
population. The role of biological factors contributing to high infection, hospitalization, and death rates in these
groups remains to be investigated. Cell entry of SARS-CoV-2 depends on binding of the viral spike (S) protein
to the host cell receptor ACE2 and its priming/cleavage by host protease TMPRSS2. It is well accepted that the
main route of the SARS CoV-2 entry into the body is via respiratory epithelial cells. However, cells in other
tissues/organs including the heart, kidney, pancreas, eye and skin (mostly epidermis) also express ACE2 and
TMPRSS2. Some recent studies indicate that skin could be directly targeted by SARS-CoV-2. Indeed, viral RNA
and capsid proteins were detectable in skin biopsies. Importantly, some inflammatory skin diseases, such as
psoriasis and atopic dermatitis, significantly increased the risk of COVID-19. This correlates with the findings
that ACE2 and TMPRSS2 expression was increased in lesional skin of psoriasis patients as well as in wounded
skin. In addition, COVID-19 is associated with dermatological immediate or sometimes persistent manifestations
which could occur because of direct (topical) or systemic (via circulating virus) infection by SARS-CoV-2.
Nevertheless, the potential role of human healthy or inflamed skin in SARS-CoV-2 entry and COVID-19
pathogenesis has not been addressed. It is known that TNF-α, IL-6, IL-1β, and IFN-γ cytokines are involved in
the development of different inflammatory skin diseases and their level is increased during cytokine storm
frequently associated with viremia, multi-organ failure, and development of severe deadly COVID-19
.
In our pilot
experiments, we showed that combination of TNF-α + IL-6 + IL-1β + INF-γ strongly induced expression of ACE2
and TMPRSS2 in 3D human skin equivalents (3D-HSE) made from primary human epidermal keratinocytes
(NHEK). Based on these novel findings, we hypothesize that inflamed skin could be infected by wild type SARS-
CoV-2 virus and its emerging mutated variants, and that higher infection rates reported for specific ethnic
populations may depend on higher expression levels of proteins involved in SARS-CoV-2 cell entry. To test these
hypotheses, we will use pseudotyped Spike (S) protein-containing reporter lentiviruses, 2D- and 3D-HSE
cultures made from AA, Hispanic and WNH keratinocytes pretreated with cytokine cocktails related to COVID-
19 cytokine storm (TNF-α+IL-6+IL-1b+INF-γ) or cytokines proven to induce pro-psoriasis (IL17+IL22+TNFa) or
pro-atopic dermatitis (IL4+IL13) molecular and morphological changes in in vitro skin models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of healthy skin molecular phenotype in the switch to specific skin diseases
-
批准号:10511569
-
项目类别:
-
资助金额:$21.77万
-
财政年份:2022
-
负责人:Irina Budunova
-
依托单位:
Role of healthy skin molecular phenotype in the switch to specific skin diseases
-
批准号:10709874
-
项目类别:
-
资助金额:$18.21万
-
财政年份:2022
-
负责人:Irina Budunova
-
依托单位:
Core D GET iN
-
批准号:10700045
-
项目类别:
-
资助金额:$12.13万
-
财政年份:2019
-
负责人:Irina Budunova
-
依托单位:
Core D GET iN
-
批准号:10259800
-
项目类别:
-
资助金额:$12.13万
-
财政年份:2019
-
负责人:Irina Budunova
-
依托单位:
Core D GET iN
-
批准号:10455750
-
项目类别:
-
资助金额:$12.13万
-
财政年份:2019
-
负责人:Irina Budunova
-
依托单位:
Integrative informatics approach to develop safe glucocorticoid therapies
-
批准号:8965299
-
项目类别:
-
资助金额:$51.68万
-
财政年份:2015
-
负责人:Irina Budunova
-
依托单位:
Integrative informatics approach to develop safe glucocorticoid therapies
-
批准号:9265107
-
项目类别:
-
资助金额:$48.65万
-
财政年份:2015
-
负责人:Irina Budunova
-
依托单位:
Integrative informatics approach to develop safe glucocorticoid therapies
-
批准号:9223338
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2015
-
负责人:Irina Budunova
-
依托单位:
DNA/RNA Delivery Core
-
批准号:7677673
-
项目类别:
-
资助金额:$13.45万
-
财政年份:2009
-
负责人:Irina Budunova
-
依托单位:
Tumor suppressor effects of GR in skin: implication of stem cells
-
批准号:8071063
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2007
-
负责人:Irina Budunova
-
依托单位:
Tumor suppressor effects of GR in skin: implication of stem cells
-
批准号:7314815
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2007
-
负责人:Irina Budunova
-
依托单位:
Tumor suppressor effects of GR in skin: implication of stem cells
-
批准号:7487042
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2007
-
负责人:Irina Budunova
-
依托单位:
Tumor suppressor effects of GR in skin: implication of stem cells
-
批准号:7617629
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2007
-
负责人:Irina Budunova
-
依托单位:
Tumor suppressor effects of GR in skin: implication of stem cells
-
批准号:7872798
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2007
-
负责人:Irina Budunova
-
依托单位:
ANALYSIS OF CONNEXIN26 IN MOUSE SKIN CARCINOGENESIS
-
批准号:6362722
-
项目类别:
-
资助金额:$22.82万
-
财政年份:2000
-
负责人:Irina Budunova
-
依托单位:
ANALYSIS OF CONNEXIN26 IN MOUSE SKIN CARCINOGENESIS
-
批准号:6633489
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2000
-
负责人:Irina Budunova
-
依托单位:
ANALYSIS OF CONNEXIN26 IN MOUSE SKIN CARCINOGENESIS
-
批准号:6128317
-
项目类别:
-
资助金额:$22.82万
-
财政年份:2000
-
负责人:Irina Budunova
-
依托单位:
ANALYSIS OF CONNEXIN26 IN MOUSE SKIN CARCINOGENESIS
-
批准号:6514136
-
项目类别:
-
资助金额:$22.82万
-
财政年份:2000
-
负责人:Irina Budunova
-
依托单位:
DNA/RNA Delivery Core
-
批准号:8322826
-
项目类别:
-
资助金额:$13.33万
-
财政年份:--
-
负责人:Irina Budunova
-
依托单位:
DNA/RNA Delivery Core
-
批准号:8901931
-
项目类别:
-
资助金额:$13.11万
-
财政年份:--
-
负责人:Irina Budunova
-
依托单位:
海外基金